357368 <common-name>N-[3-(dimethylamino)propyl]-10-[2-[8-[3-(dimethylamino)propylamino]-8-oxooctyl]-5,6-dihexylcyclohex-3-en-1-yl]dec-9-enamide</common-name> <description>N-[3-(dimethylamino)propyl]-10-[2-[8-[3-(dimethylamino)propylamino]-8-oxooctyl]-5,6-dihexylcyclohex-3-en-1-yl]dec-9-enamide is a chemical compound with the formula C46H88N4O2. With an average molecular weight of 729.20 g/mol, N-[3-(dimethylamino)propyl]-10-[2-[8-[3-(dimethylamino)propylamino]-8-oxooctyl]-5,6-dihexylcyclohex-3-en-1-yl]dec-9-enamide is a heavy molecule.</description> <cas>120174-68-7</cas> <pubchem-id>91864481</pubchem-id> <chemical-formula>C46H88N4O2</chemical-formula> <weight>729.2</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-09-01T04:26:17Z</created-at> <updated-at type="dateTime">2026-09-01T04:26:17Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCCCC1C=CC(C(C1CCCCCC)C=CCCCCCCCC(=O)NCCCN(C)C)CCCCCCCC(=O)NCCCN(C)C</moldb-smiles> <moldb-formula>C46H88N4O2</moldb-formula> <moldb-inchi>InChI=1S/C46H88N4O2/c1-7-9-11-21-29-41-35-36-42(30-22-17-16-20-26-34-46(52)48-38-28-40-50(5)6)44(43(41)31-23-12-10-8-2)32-24-18-14-13-15-19-25-33-45(51)47-37-27-39-49(3)4/h24,32,35-36,41-44H,7-23,25-31,33-34,37-40H2,1-6H3,(H,47,51)(H,48,52)</moldb-inchi> <moldb-inchikey>MFUARKCVEHMGDO-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">728.6907281</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>13.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM353261</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[3-(dimethylamino)propyl]-10-[2-[8-[3-(dimethylamino)propylamino]-8-oxooctyl]-5,6-dihexylcyclohex-3-en-1-yl]dec-9-enamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Lipids and lipid-like molecules</superklass> <klass>Fatty Acyls</klass> <subklass>Fatty amides</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0307616</sync-id> <structure-inchikey>MFUARKCVEHMGDO-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>400000000080000000000000000000000000000c000000000000000000000002000810000200000000000000404000000000000000004000000000000000000000000000010400000020000028001000000600000000000000000001000020010000008000000000004000000001000020200000000000000000100000000040000010000000000000010080100000000000000008000000001000000000000000000000080010000000000000000088000000000000000000000000000048000004000000000000000800000000000000020020000000000000000000000000000000000048000000010400000001000000000000000000000100</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAA0AAAANAAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAwEGAGgA AAADAwEGAGgAAAADAwEGAGAAAAADAQYAYAAAAAMBBgBgAAAAAwEGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAQMGAGgA AAADAwEGAGgAAAADAwEGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHAGgA AAADAgEGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIHACAAAAADBgBgAAAAAQMG AGAAAAABAwYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAA AgIGAGAAAAACAgYAYAAAAAICBgAoAAAAAwQIACgAAAADAgcAaAAAAAMCAQYA YAAAAAICBgBgAAAAAgIGAGAAAAACAgcAIAAAAAMGAGAAAAABAwYAYAAAAAED CwABAAECAAIDAAMEAAQFAAUGAAYHAAcICAIICQAJCgAKCwALDAAMDQANDgAO DwAPEAAQEQAKEgASEwgCExQAFBUAFRYAFhcAFxgAGBkAGRoAGhsAGxwoAhsd IB0eAB4fAB8gACAhACEiACEjAAkkACQlACUmACYnACcoACgpACkqACorACss KAIrLSAtLgAuLwAvMAAwMQAxMgAxMwALBgBCAQAAAAYGCwoJCAcXBAAAAAAA AAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:55:09Z</structure-indexed-at> </compound>